Bio-Reference Laboratories (BRLI -24.7%) nosedives following a scathing column from...
Friday, November 11, 2011, 11:53 AM ETBio-Reference Laboratories (BRLI -24.7%) nosedives following a scathing column from TheStreetSweeper, alleging (among other things) a "culture of corruption" and ties to organized crime. It doesn't help that Jefferies is responding by putting its Hold rating under review, believing TheStreetSweeper's report could lead to regulatory scrutiny.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles